Intelligent Bio Solutions Inc Ordinary Shares INBS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.66
- Day Range
- $1.66–1.70
- 52-Week Range
- $1.55–24.58
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 3.32M
- Market Cap
- $5.51M
- Volume/Avg
- 43,696 / 157,227
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.58
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 60
- Website
- https://www.ibs.inc
Valuation
|
Metric
|
INBS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.88 |
Price/Sales | 0.58 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
INBS
|
|---|---|
Quick Ratio | 1.15 |
Current Ratio | 1.44 |
Interest Coverage | −1,170.67 |
Quick Ratio
INBS
Profitability
|
Metric
|
INBS
|
|---|---|
Return on Assets (Normalized) | −94.93% |
Return on Equity (Normalized) | −185.08% |
Return on Invested Capital (Normalized) | −154.01% |
Return on Assets
INBS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<Hq<Xt | LOCK|ggmY | $169B | |||
| Medtronic PLC
MDT
| LOCK|HJQtCx> | LOCK|^<b@B | $110B | |||
| Stryker Corp
SYK
| LOCK|lb@Jwjk | LOCK|#L | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|#<!^!S | LOCK|>hv>r | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|vCt>R&@? | LOCK|$Xrq | $49B | |||
| DexCom Inc
DXCM
| LOCK|<v>kcQD | LOCK|H#vw | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|x>mb&f | LOCK|^LT | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|hLp | LOCK|PXy | $23B | |||
| Steris PLC
STE
| LOCK|D@#<ZlB | LOCK|mM^P | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^fHV%@b | LOCK|>! | $17B |
United States